Refining esophageal cancer staging after neoadjuvant therapy: Importance of treatment response

Annals of Surgical Oncology

Volumn 15, Issue 10, 2008, Pages 2894-2902

  Barbour, Andrew P ^a   Jones, Mark ^a   Gonen, Mithat ^b   Gotley, David C ^a   Thomas, Janine ^a   Thomson, Damien B ^a   Burmeister, Bryan ^a   Smithers, B Mark ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemoradiotherapy; Esophageal cancer; Prognostic factors; Staging

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PROGNOSIS; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 51649129253     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0084-y     Document Type: Article

References (41)

1. T Lerut W Coosemans G Decker 2004 Extended surgery for cancer of the esophagus and gastroesophageal junction J Surg Res 117 58 63
2. SM Griffin J Wayman 2002 Sub-total oesophagectomy with 2 field lymphadenectomy Minerva Chir 57 753 66
3. KM Chu SY Law M Fok 1997 A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma Am J Surg 174 320 4
4. JB Hulscher JW van Sandick AG de Boer 2002 Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 1662 9
5. JS Macdonald SR Smalley J Benedetti 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 30
6. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359:1727-33
7. D Cunningham WH Allum SP Stenning 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20
8. DP Kelsen R Ginsberg TF Pajak 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1979 84
9. TN Walsh N Noonan D Hollywood 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 7
10. BH Burmeister BM Smithers V Gebski 2006 Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 659 68
11. V Gebski B Burmeister BM Smithers 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 226 34
12. M Stahl M Stuschke N Lehmann 2005 Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2310 7
13. BL Brucher K Becker F Lordick 2006 The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas Cancer 106 2119 27
14. AM Mandard F Dalibard JC Mandard 1994 Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 2680 6
15. SG Swisher W Hofstetter TT Wu 2005 Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT) Ann Surg 241 810 7
16. WA Weber K Ott K Becker 2001 Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J Clin Oncol 19 3058 65
17. NP Rizk E Venkatraman MS Bains 2007 American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma J Clin Oncol 25 507 12
18. SG Swisher W Hofstetter TT Wu 2005 Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT) Ann Surg 241 810 7
19. PM Schneider SE Baldus R Metzger 2005 Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 684 92
20. Green FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual, 6th edition. Springer-Verlag, New York, NY, 2002:111-9
21. JR Siewert M Feith M Werner 2000 Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients Ann Surg 232 353 61
22. M Suntharalingam ML Haas JR Sonett 2001 Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma Cancer J 7 509 15
23. BM Smithers DC Gotley I Martin 2007 Comparison of the outcomes between open and minimally invasive esophagectomy Ann Surg 245 232 40
24. LR Chirieac SG Swisher JA Ajani 2005 Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation Cancer 103 1347 55
25. M Gonen G Heller 2005 Concordance probability and discriminatory power in proportional hazards regression Biometrika 92 965 70
26. TN Walsh N Noonan D Hollywood 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 7
27. SG Swisher J Erasmus M Maish 2004 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma Cancer 101 1776 85
28. SG Swisher M Maish JJ Erasmus 2004 Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer Ann Thorac Surg 78 1152 60
29. PR Rohatgi SG Swisher AM Correa 2005 Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus Cancer 104 1349 55
30. JL Lee SI Park SB Kim 2004 A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma Ann Oncol 15 947 54
31. JS Donington DL Miller MS Allen 2003 Tumor response to induction chemoradiation: influence on survival after esophagectomy Eur J Cardiothorac Surg 24 631 6
32. C Torres JR Turner HH Wang 1999 Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients Cancer 85 520 8
33. SJ Swanson HF Batirel R Bueno 2001 Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma Ann Thorac Surg 72 1918 24
34. Y Gu SG Swisher JA Ajani 2006 The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation Cancer 106 1017 25
35. MA Eloubeidi R Desmond MR Arguedas 2002 Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status Cancer 95 1434 43
36. EA Griffiths Z Brummell G Gorthi 2006 Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses J Surg Oncol 93 258 67
37. Beahrs OH, Meyers MH, eds. Manual for Staging of Cancer. JB Lippincott, Philadelphia, PA, 1983:61-6
38. MS Sabel JL Smith HR Nava 2002 Esophageal resection for carcinoma in patients older than 70 years Ann Surg Oncol 9 210 4
39. JB Jougon M Ballester J Duffy 1997 Esophagectomy for cancer in the patient aged 70 years and older Ann Thorac Surg 63 1423 7
40. AH Moskovitz NP Rizk E Venkatraman 2006 Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer Ann Thorac Surg 82 2031 6
41. JM Blazeby D Alderson JR Farndon 2000 Quality of life in patients with oesophageal cancer Recent Results Cancer Res 155 193 204